An overactive neddylation pathway serves as a therapeutic target and MLN4924 enhances the anticancer activity of cisplatin in pancreatic cancer. [electronic resource]
Publication details: Oncology letters Sep 2019Description: 2724-2732 p. digitalISSN:- 1792-1074
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.